Probotic strain of lactobacillus reuteri exhibiting ant-helicobacter activity, a probiotic or biotherapeutic product comprising said strain, and the use thereof

[EN] The invention relates to a new strain of Lactobacillus reuteri isolated from the human stomach, exhibiting antioxidant and antimicrobial activity, in particular an anti-Helicobacter effect, considerable resistance to the conditions of the gastric ecosystem, and the capacity to adhere to the epi...

Descripción completa

Detalles Bibliográficos
Autores: Mayo Pérez, Baltasar, Delgado, Susana
Tipo de recurso: artículo
Fecha de publicación:2014
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/126893
Acceso en línea:http://hdl.handle.net/10261/126893
Access Level:acceso abierto
Descripción
Sumario:[EN] The invention relates to a new strain of Lactobacillus reuteri isolated from the human stomach, exhibiting antioxidant and antimicrobial activity, in particular an anti-Helicobacter effect, considerable resistance to the conditions of the gastric ecosystem, and the capacity to adhere to the epithelium. The invention also relates to a probiotic or biotherapeutic product which contains the strain of L. reuteri and is suitable for use in the treatment or prophylaxis of gastric diseases caused by the Helicobacter pylori bacteria, in order to prevent the secondary effects associated with conventional antibiotic treatments.